Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva
Moderna stock ($MRNA) fell 1.5% to $55.39 on Thursday despite getting big news from health regulators. The Food and Drug Administration approved Mo...
Moderna Inc. (MRNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 134,800 | $9,440,044 | -56% | 0.03% | |
| 2. | 113,700 | $7,962,411 | -30% | 0.03% | |
| 3. | Fisher Asset Management Ken Fisher | 10,854 | $760,172 | 0% | |
| 4. | Bayforest Capital Theodoros Tsagaris | 2,064 | $144,542 | -48% | 0.13% |
| 5. | Walleye Capital Will England | 781 | $54,693 | +357% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.53 | 57,493 | $1,812,754.29 | 9,210,686 | 2025-03-03 | Filing | |
| $31.04 | 102,821 | $3,191,563.84 | 9,153,193 | 2025-03-03 | Filing | |
| $31.76 | 31,620 | $1,004,251.20 | 312,027 | 2025-03-03 | Filing | |
| $19.00 | 52,631 | $999,989.00 | 420,407 | 2020-02-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $67.60 | 53,336 | $3,605,513.60 | 1,483,848 | 2026-07-15 | Filing | |
| $51.37 | 53,336 | $2,739,870.32 | 1,483,848 | 2026-06-15 | Filing | |
| $50.00 | 3,471 | $173,550.00 | 67,468 | 2026-06-04 | Filing | |
| $46.84 | 9,263 | $433,878.92 | 3,924 | 2026-05-21 | Filing | |
| $48.40 | 53,336 | $2,581,462.40 | 1,477,997 | 2026-05-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,699,402 | $189,039,122 | 1.18% | |
| 2. | 2,165,414 | $151,643,942 | 0.05% | |
| 3. | 1,343,479 | $94,083,834 | 1.28% | |
| 4. | 763,907 | $53,496,407 | 1.15% | |
| 5. | 602,100 | $42,165,063 | 0.05% |
News See All
Moderna Stock (MRNA) Jumps on U.S. Approval for New Flu Shot Type — Why This Matters
Shares in Moderna ($MRNA) rose about 4% early Thursday after the pharma and biotech firm received the go-ahead from the U.S. health watchdog to sel...
Moderna Wins a Post-COVID Earnings Beat as Analyst Eyes ‘Clinically Meaningful’ Trial Results
Moderna’s ($MRNA) latest earnings were better-than-expected. Jefferies ($JEF) analyst Andrew Tsai explained that while quarterly earnings beat expe...
Polymarket Odds: Will MRNA, XOM, CVX Beat Earnings Tomorrow?
On Friday, July 31, Moderna ($MRNA), Exxon Mobil ($XOM), and Chevron ($CVX) will release their earnings. All three companies will report before the...
Moderna Stock Has Doubled in 2026, But Wall Street Still Isn't Convinced
The year 2026 has turned into a pivotal year for the biotech capital markets.
10 Best Performing American Stocks in June 2026
Fidelity says “Market breadth has broadly remained strong” and “unrelenting corporate earnings growth has underpinned stocks.” That suggests some recent rallies are happening in a market still...
Jim Cramer’s Comments on 25 Stocks Like Micron, Dell, and Playing the Recent Market Rotation
In this article, we will look at the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation.
10 Stocks With Standout Gains
Coupang saw its share prices jump by 5.25 percent on Tuesday to close at $18.03 apiece, as investors traded while awaiting updates on its appeal in relation to a $410 million penalty imposed by South ...
Moderna (MRNA) Climbs 7.5% Ahead of Next Week's Key Updates
In a notice to investors, Moderna Inc. (NASDAQ:MRNA) said that it is set to join in the Goldman Sachs’ 47th Annual Global Healthcare Conference on Tuesday, June 9.